Found: 28
Select item for more details and to access through your institution.
Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05492-5
- By:
- Publication type:
- Article
Comparison of liver scintigraphy and the liver-spleen contrast in Gd-EOB-DTPA-enhanced MRI on liver function tests.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01815-0
- By:
- Publication type:
- Article
Helicobacter fennelliae Localization to Diffuse Areas of Human Intestine, Japan.
- Published in:
- Emerging Infectious Diseases, 2024, v. 30, n. 1, p. 129, doi. 10.3201/eid3001.231049
- By:
- Publication type:
- Article
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 2, p. 1, doi. 10.1002/jmv.28452
- By:
- Publication type:
- Article
Positivity of high‐sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non‐HBV‐related HCC.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1315, doi. 10.1111/apt.18229
- By:
- Publication type:
- Article
Characterization of liver-cirrhosis nodules by analysis of gene-expression profiles and patterns of allelic loss.
- Published in:
- Journal of Human Genetics, 2004, v. 49, n. 5, p. 246, doi. 10.1007/s10038-004-0141-8
- By:
- Publication type:
- Article
Isolation of Not I Clusters Hypomethylated in HBV-integrated Hepatocellular Carcinomas by Two-Dimensional Electrophoresis.
- Published in:
- DNA Research, 1999, v. 6, n. 4, p. 219, doi. 10.1093/dnares/6.4.219
- By:
- Publication type:
- Article
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria.
- Published in:
- Hepatology Research, 2021, v. 51, n. 9, p. 979, doi. 10.1111/hepr.13693
- By:
- Publication type:
- Article
Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria.
- Published in:
- Hepatology Research, 2020, v. 50, n. 8, p. 966, doi. 10.1111/hepr.13511
- By:
- Publication type:
- Article
Entecavir treatment of hepatitis B virus‐infected patients with severe renal impairment and those on hemodialysis.
- Published in:
- Hepatology Research, 2019, v. 49, n. 11, p. 1294, doi. 10.1111/hepr.13399
- By:
- Publication type:
- Article
Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter.
- Published in:
- Hepatology Research, 2019, v. 49, n. 10, p. 1207, doi. 10.1111/hepr.13391
- By:
- Publication type:
- Article
Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3938, doi. 10.3390/cancers14163938
- By:
- Publication type:
- Article
Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma.
- Published in:
- PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0247728
- By:
- Publication type:
- Article
Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-019-56947-1
- By:
- Publication type:
- Article
Characteristics of Human Hepatocellular Carcinoma Cell Lines (Hep-KANO) Derived from a Non-hepatitic, Non-cirrhotic Hepatitis B Virus Carrier.
- Published in:
- Cancer Science, 1994, v. 85, n. 11, p. 1105, doi. 10.1111/j.1349-7006.1994.tb02914.x
- By:
- Publication type:
- Article
Establishment and characteristics of a gastric cancer cell line (HuGC-OOHIRA) producing high levels of G-CSF, GM-CSF, and IL-6: The presence of autocrine growth control by G-CSF.
- Published in:
- American Journal of Hematology, 1995, v. 49, n. 3, p. 207, doi. 10.1002/ajh.2830490306
- By:
- Publication type:
- Article
Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 1, p. 181, doi. 10.3390/v15010181
- By:
- Publication type:
- Article
Risk Factors for Recurrent Helicobacter cinaedi Bacteremia and the Efficacy of Selective Digestive Decontamination With Kanamycin to Prevent Recurrence.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 4, p. 573, doi. 10.1093/cid/ciy114
- By:
- Publication type:
- Article
First evidence of bacterial translocation from the intestinal tract as a route of <italic>Helicobacter cinaedi</italic> bacteremia.
- Published in:
- Helicobacter, 2018, v. 23, n. 1, p. 1, doi. 10.1111/hel.12458
- By:
- Publication type:
- Article
Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection.
- Published in:
- Journal of Gastroenterology, 2021, v. 56, n. 2, p. 168, doi. 10.1007/s00535-020-01750-3
- By:
- Publication type:
- Article
Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Universal admission screening for COVID-19 using quantitative antigen testing and questionnaire screening to prevent nosocomial spread.
- Published in:
- PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0277426
- By:
- Publication type:
- Article
Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 5, p. 769, doi. 10.1007/s11523-024-01092-7
- By:
- Publication type:
- Article
Discrimination of individuals in a general population at high-risk for alcoholic and non-alcoholic fatty liver disease based on liver stiffness: a cross section study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world setting.
- Published in:
- JGH Open, 2020, v. 4, n. 1, p. 54, doi. 10.1002/jgh3.12209
- By:
- Publication type:
- Article
DNA alterations during multi-step development of human hepatocellular carcinomas revealed by laser capture microdissection
- Published in:
- Hepatology Research, 2003, v. 26, n. 3, p. 199, doi. 10.1016/S1386-6346(03)00110-4
- By:
- Publication type:
- Article
Chronic hepatitis C associated with monoclonal gammopathy of undetermined significance.
- Published in:
- Journal of Gastroenterology & Hepatology, 2003, v. 18, n. 4, p. 459, doi. 10.1046/j.1440-1746.2003.02800.x
- By:
- Publication type:
- Article